Your Questions Answered about Coronavirus (COVID-19)

Please note, with the fast developing knowledge on this topic, some recommendations may change as new data emerges. Click here to access the latest LLS information and resources on COVID-19.

Two hematologist/oncologists on the LLS leadership team, and experts in the field of blood cancer, answer questions and concerns about coronavirus (COVID-19).


 

Audio Replay

Program Materials

/sites/default/files/2021-05/slides_covid-19_3.26.20.pdf
/sites/default/files/2021-05/transcript_covid-19_3.26.20.pdf
/sites/default/files/2021-05/Online_and_Virtual_Support_during_COVID-19_Mar2020_0.pdf

Speakers

Gwen Nichols, MD
Chief Medical Officer
The Leukemia & Lymphoma Society

Ruben A. Mesa, MD, FACP
Director, Mays Cancer Center at UT Health San Antonio MD Anderson
Mays Family Foundation Distinguished University Presidential Chair
Professor of Medicine
Board Member, LLS National Board of Directors

Program Support

Support for this program is provided by AbbVie Inc., Autolus Therapeutics plc, Bristol Myers Squibb Foundation, and  Pharmacylics, An AbbVie Company & Janssen Biotech.

 

The Leukemia & Lymphoma Society (LLS) is closely monitoring the coronavirus (COVID-19) pandemic. For more information and resources, click here. 
 

 

< Back to Webcasts

 

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.